Pharma trade organisations in the US have told President Trump that tariffs such as the 10% levy on Chinese imports could drive up the cost of generic medicines, impact supply chains, and exacerbate ...
President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...
Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.
Today’s fast globalization makes supply chains more intricate by involving various nations, parties, and business steps.
“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...
New Black Book Research survey reveals industry-wide concerns as tariffs on imports from Mexico, Canada, and China threaten ...
Trade groups representing pharma distributors and generic/biosimilar industries express concerns over potential tariffs on ...
President Trump’s tariffs will include imported pharmaceuticals, among other items that will impact the industry.
AdvaMed, the largest medical device association globally, urged the Trump administration to exempt medical products from the ...
Respondents agreed that the level of risk in pharmaceutical supply chains has increased across the board since 2023, although perceptions about the degree of escalation vary. Fifty-six (56%) percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback